A study was carried out in which activity of gammaglutamyl transpeptidase was measured in 259 samples of amniotic fluid obtained at various weeks of pregnancy.
Pregnancy (weeks ) y-Glutamyl transpeptidase activity in early amniotic fluid. at 15 to 16 weeks was one-third (204 U/i) of that observed in the controls (598 U/i) (p <00005). In Down's syndrome (fig (B) ) the activity averaged 322 U/i (p <00005) and fell below the 2-5th percentile in nine of the 19 samples. The activity was within the normal range in one case of XO disorder (at 18 weeks; not shown).
Discussion
Activity of y-glutamyl transpeptidase in early amniotic fluid was up to 100 times higher than that observed previously in maternal serum.' Siegers et a13 reported that the mean activity in 17 samples of amniotic fluid obtained at 15-26 weeks' gestation was 426 U/l. Our results agree with these findings. y-Glutamyl transpeptidase probably enters the amniotic fluid from the surrounding fetal tissues, not from the maternal blood. This hypothesis is favoured by our recent findings that most of the enzyme activity is bound to complexes of high molecular weight, as analysed by gel filtration, and that the enzyme is demonstrable in several fetal tissues, such as the kidneys, small bowel, lungs, amniotic membranes, and placenta (unpublished observations).
To our knowledge this is the first time that a biochemical "disorder" has been observed in amniotic fluid in pregnancies in which the fetus is affected by a chromosome abnormality. The low y-glutamyl transpeptidase activity is unlikely to be due to a specific gene disorder, since it occurred, to a variable extent, in several different syndromes. Autosomal abnormalities, especially trisomy 18, adversely affect prenatal growth,4 and the low enzyme activity may be caused by reduced leakage of the enzyme from hypoplastic fetal tissues. The low activity cannot, however, be explained solely by the growth deficiency, since in normal pregnancies the growth of the fetus is accompanied by a decrease, not increase, in amniotic fluid y-glutamyl transpeptidase activity.
In our assay, in 74%O of the samples from women whose fetuses had chromosomal aberrations activity of the enzyme was below the 10th percentile. If the activity was less than 300 U/i at 15-16 weeks' gestation there was a 75%,, probability of chromosomal disorder, and if it was less than 200 U/I (10 samples) the probability was 1000.
The importance of these findings remains to be established, but assay of y-glutamyl transpeptidase activity would appear to be a useful additional test for prenatal diagnosis of chromosomal aberrations. The method is fast and simple and in common use in clinical laboratories for diagnosis of liver diseases. A prospective controlled trial was carried out to assess the effect of using a wound isolator on reducing postoperative infection. A total of 291 patients undergoing hip pinning for fractures of the neck of femur entered the trial and were allocated at random to have their wound contained in a wound isolator (study group) or dressed with a standard gamma-irradiated adhesive dressing (control group). The bacteriological flora of the patient was monitored before, during, and after operation and that of the ward before and after. No significant difference was found in the flora of the wards in which the patients were nursed. On several occasions the source of the infective organism was traced to the ward but never to the theatre.
The isolator prevented direct contamination and airborne cross-infection of the wound and appreciably reduced the rate of infection.
Introduction
Wound infection is one of the most serious problems in surgery and argument continues on the relative importance of the various sources of infection in the total environment of the patient undergoing surgery. With the advent of total hip replacement the unacceptably high incidence of postoperative wound infection led workers to look more closely at the environment of the patient and particularly at the theatre environment and routine. Professor Sir John Charnley felt that infection after total hip replacement was caused by organisms from the theatre atmosphere settling into the wound. After introducing a clean air theatre with 300 air changes per hour and a body exhaust system he reduced his infection rate after low-triction arthroplasty from 9 5"' to 04".' Unfortunately insufficient monitoring of the bacteriological flora of the patient's total environment in such studies leaves doubt as to the exact source of any infection. We therefore conducted a study of the surgical isolator2 in total hip replacement, monitoring the bacteriological flora of the patient before, during, and after every operation and of the operative environment during every procedure. We found that the opportunities for superficial or deep infection were greater in the ward than in the operating theatre.: As a result of these findings a sterile microenvironment for postoperative wound care was developed. This isolator (figure) contains wounds in a sterile environment until they have healed and prevents direct contact and airborne cross-infection. We describe the efficiency of this sterile microenvironment in reducing postoperative wound infection after hip pinning.
